Quizartinib |
AC-220; ASP-2689; AC-010220 |
Approved |
Ambit Biosciences |
Vanflyta |
Japan |
Leukemia, Myeloid, Acute |
Daiichi Sankyo Co Ltd |
2019-06-18 |
Leukemia, Myeloid, Acute |
Details
|
Sorafenib Tosylate |
NSC-724772; BAY-43-0006; BAY-43-9006; BAY-54-9085 |
Approved |
Onyx Pharmaceuticals Inc |
Nexavar, 多吉美 |
EU |
Thyroid Neoplasms |
Bayer AG |
2005-12-01 |
Lung Neoplasms; Adrenocortical Carcinoma; Mesothelioma; Breast Neoplasms; Hepatitis B; Prostatic Neoplasms; Brain Neoplasms; Sarcoma; Pulmonary Arterial Hypertension; Medullary thyroid cancer (MTC); Hepatitis C; Thyroid Neoplasms; Leukemia, Monocytic, Acute; Lymphoma, T-Cell; Digestive System Neoplasms; Leukemia, Myeloid, Acute; Glioma; Venous Thrombosis; Facial Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma; Adenocarcinoma; Fasting; Leukemia, Biphenotypic, Acute; Leukemia, Lymphocytic, Chronic, B-Cell; Neoplasms; Ovarian Neoplasms; Hematopoietic stem cell transplantation (HSCT); Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Solid tumours; Kidney Neoplasms; Recurrence; Carcinoma, Renal Cell; Carcinoma; Stomach Neoplasms; Abdominal Neoplasms; Esophageal Neoplasms; Pancreatic Neoplasms; Liver Neoplasms; Neoplasms, Glandular and Epithelial; Kidney Diseases; Myelodysplastic Syndromes; Myeloproliferative Disorders; Thyroid |
Details
|
Pexidartinib |
PLX-3397 |
Approved |
Daiichi Sankyo Co Ltd |
Turalio |
United States |
Giant Cell Tumor of Tendon Sheath |
Daiichi Sankyo Inc |
2019-08-02 |
Giant Cell Tumor of Tendon Sheath; Solid tumours; Synovitis, Pigmented Villonodular; Hodgkin Disease; Glioblastoma; Neoplasms; Giant Cell Tumors; Prostatic Neoplasms; Gastrointestinal Stromal Tumors; Leukemia, Myeloid, Acute; Melanoma |
Details
|
Ponatinib Hydrochloride |
AP24534 hydrochloride; AP24534-HCL; AP24534 HCl; INCB-84344; AP-24534 |
Approved |
Ariad |
Iclusig |
Japan |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
Otsuka Holdings Co Ltd |
2012-12-14 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma; Carcinoma, Non-Small-Cell Lung; Leukemia, Biphenotypic, Acute; Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Myeloid, Chronic-Phase; Gastrointestinal Stromal Tumors; Philadelphia Chromosome; Medullary thyroid cancer (MTC); Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Blast Crisis; Small Cell Lung Carcinoma; Adenocarcinoma of Lung; Solid tumours; Leukemia, Myeloid, Accelerated Phase; Leukemia; Hematologic Neoplasms |
Details
|
Brigatinib |
AP-26113 |
Approved |
Ariad, Takeda Pharmaceutical Co Ltd |
Alunbrig |
Mainland China |
Carcinoma, Non-Small-Cell Lung |
Takeda (China) International Trading Co Ltd |
2017-04-28 |
Solid tumours; Ependymoma; Carcinoma; Neurofibromatosis 2; Neoplasms; Myofibroma; Granuloma, Plasma Cell; Lung Neoplasms; Lymphoma, Large-Cell, Anaplastic; Brain metastases; Carcinoma, Non-Small-Cell Lung; Meningioma; Neurilemmoma; Neuroma, Acoustic |
Details
|
Midostaurin |
PKC-412; PKC-412A; CGP-41231; CGP-41251 |
Approved |
Novartis Pharma Ag |
Rydapt |
EU |
Leukemia, Myeloid, Acute; Mastocytosis |
Novartis Europharm Ltd |
2017-04-28 |
Hematologic Neoplasms; Leukemia; Mastocytosis, Systemic; Myelodysplastic Syndromes; Leukemia, Mast-Cell; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Hepatic Insufficiency; Leukemia, Myeloid, Acute; Mastocytosis |
Details
|
Cabozantinib S-malate |
XL-184; BMS-907351 |
Approved |
Exelixis Inc |
Cometriq, Cabometyx |
Japan |
Carcinoma, Renal Cell |
Takeda |
2012-11-29 |
Thyroid Neoplasms; Adenocarcinoma, Follicular; Brain Neoplasms; Sarcoma; Neuroblastoma; Neurofibroma, Plexiform; Prostatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Astrocytoma; Hepatic Insufficiency; Bile Duct Neoplasms; Central Nervous System Neoplasms; Lymphoma; Leukemia, Myeloid, Acute; Glioma; Carcinoma, Neuroendocrine; Carcinoma, Hepatocellular; Neoplasms, Germ Cell and Embryonal; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Thyroid Cancer, Papillary; Meningioma; Carcinoma, Transitional Cell; Kidney Neoplasms; Ovarian germ cell tumor; Bone metastases; Carcinoma, Renal Cell; Rejection of liver transplantation; Esophageal Neoplasms; Pain; Stomach Neoplasms; Carcinoma, Merkel Cell; Glioblastoma; Seminoma; Solid tumours; Neurofibromatoses; Neoplasms; Salivary Gland Neoplasms; Carcinoma, Papillary; Skin Neoplasms; Kidney Diseases; Neuroendocrine Tumors; Adrenocortical Carcinoma; Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma |
Details
|
Fedratinib |
TG-101348; SAR-302503 |
Approved |
Sanofi |
Inrebic |
EU |
Primary Myelofibrosis; Splenomegaly |
Bristol Myers Squibb Srlcompany |
2019-08-16 |
Hematologic Neoplasms; Solid tumours; Polycythemia Vera; Kidney Diseases; Myeloproliferative Disorders; Leukemia, Neutrophilic, Chronic; Primary Myelofibrosis; Hepatic Insufficiency; Splenomegaly; Thrombocythemia, Essential |
Details
|
Nintedanib Esylate |
BIBF-1120 |
Approved |
C.H. Boehringer Sohn Ag & Co. Kg |
Ofev, Vargatef |
EU |
systemic sclerosis-associated interstitial lung disease |
Boehringer Ingelheim International Gmbh |
2014-10-15 |
Genital Neoplasms, Female; Sarcoma; Prostatic Neoplasms; systemic sclerosis-associated interstitial lung disease; Breast Neoplasms; Adenocarcinoma, Clear Cell; Peritoneal Neoplasms; Colorectal Neoplasms; Astrocytoma; Hepatic Insufficiency; Oligodendroglioma; Bronchitis; Silicosis; Gliosarcoma; Appendiceal Neoplasms; Fallopian Tube Neoplasms; Carcinoma, Squamous Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular; Idiopathic Pulmonary Fibrosis; Head and Neck Neoplasms; Telangiectasia, Hereditary Hemorrhagic; Bronchiolitis Obliterans; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Rejection of lung transplantation; Carcinoma, Renal Cell; Scleroderma, Systemic; Ovarian Neoplasms; Neoplasms; Carcinoma, Transitional Cell; Glioblastoma; Small Cell Lung Carcinoma; Pulmonary Fibrosis; Lung Diseases, Interstitial; Multiple Myeloma; Asbestosis |
Details
|
Gilteritinib Fumarate |
ASP-2215; 66D-92MGC8M (UNII code); ASP-2215 hemifumarate |
Approved |
Astellas Pharma Inc |
Xospata |
Mainland China |
Leukemia, Myeloid, Acute |
Astellas Pharmaceutical (China) Co Ltd |
2018-09-21 |
Solid tumours; Renal Insufficiency; Hepatic Insufficiency; Leukemia, Myeloid, Acute |
Details
|
Pacritinib |
SB-1518; ONX-0803 |
Approved |
Syncore Biotechnology Co Ltd, Concert |
VONJO |
United States |
Primary Myelofibrosis |
Cti Biopharma Corp |
2022-02-28 |
Breast Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Thrombocythemia, Essential; Lymphoma, T-Cell; Waldenstrom Macroglobulinemia; Thrombocytopenia; Lymphoma, T-Cell, Cutaneous; Lymphoma, Non-Hodgkin; Lymphoma; Leukemia, Myeloid, Acute; Lymphoproliferative Disorders; Colorectal Neoplasms; Primary Myelofibrosis; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Coronavirus Infections; Lymphoma, Mantle-Cell; Coronavirus Disease 2019 (COVID-19); Leukemia, Myelomonocytic, Chronic; Hodgkin Disease; Myeloproliferative Disorders; Myelodysplastic Syndromes; Polycythemia Vera; Lymphoma, T-Cell, Peripheral; Leukemia; Lymphoma, B-Cell |
Details
|
Sunitinib Malate |
PHA-290940; SU-010398; SU-11248; PNU-290940AD; PHA-290940AD; GB-102; PNU-290940; SU-011248-L-malate salt |
Approved |
Pfizer Pharmaceuticals Ltd (China) |
索坦, Sutent |
Japan |
Pancreatic neuroendocrine tumors (pNET) |
Pfizer Inc |
2006-01-26 |
Diabetic macular oedema; Thyroid Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Peritoneal Neoplasms; Astrocytoma; Thymus Neoplasms; Urologic Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Thymoma; Neurofibroma, Plexiform; Cholangiocarcinoma; Medullary thyroid cancer (MTC); Brain Neoplasms; Urethral Neoplasms; Prostatic Neoplasms; Sarcoma; Breast Neoplasms; Adrenocortical Carcinoma; Adenocarcinoma; Paraganglioma; Melanoma; Thyroid Cancer, Papillary; Retinal Vein Occlusion; Meningioma; von Hippel-Lindau Disease; Neoplasm Metastasis; Macular Degeneration; Carcinoma, Hepatocellular; Adenocarcinoma, Follicular; Carcinoma, Non-Small-Cell Lung; Fallopian Tube Neoplasms; Neoplasms, Gonadal Tissue; Nervous System Neoplasms; Germinoma; Brain metastases; Hemangiopericytoma; Urogenital Neoplasms; Hemangioblastoma; Glioblastoma; Pheochromocytoma; Pelvic Neoplasms; Thoracic Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Carcinoma, Islet Cell; Histiocytom |
Details
|